A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.
Status:
Completed
Trial end date:
2017-06-27
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and the safety of YH23537 in Korea patients
with chronic periodontitis, in order to investigate the recommended therapeutic dose.